ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 574,07
-0,81%
Dow Jones
42 226,64
-0,24%
DAX
19 213,14
-0,67%
Brent Oil
73,785
2,50%
Bitcoin
62 050,46
-2,02%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aptevo Therapeutics Inc (APVO)

  7. Aptevo Therapeutics Inc (APVO) Actualités

APVO

Aptevo Therapeutics (APVO)

Aptevo Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:APVO
DateHeureSourceTitreSymboleSociété
23/09/202422h48Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
18/09/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APVOAptevo Therapeutics Inc
17/09/202423h28Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:APVOAptevo Therapeutics Inc
17/09/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APVOAptevo Therapeutics Inc
30/08/202423h26Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:APVOAptevo Therapeutics Inc
09/08/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APVOAptevo Therapeutics Inc
08/08/202414h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APVOAptevo Therapeutics Inc
17/07/202416h25AllPennyStocks.comBiotech Seeing Significant Buying Pressure Before The Opening BellNASDAQ:APVOAptevo Therapeutics Inc
15/07/202414h19Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APVOAptevo Therapeutics Inc
12/07/202422h30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APVOAptevo Therapeutics Inc
05/03/202414h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:APVOAptevo Therapeutics Inc
30/01/202414h00Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:APVOAptevo Therapeutics Inc
22/11/202322h05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APVOAptevo Therapeutics Inc
01/08/202322h01Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APVOAptevo Therapeutics Inc
02/06/202322h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APVOAptevo Therapeutics Inc
02/06/202322h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APVOAptevo Therapeutics Inc
19/04/202314h32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:APVOAptevo Therapeutics Inc
18/04/202314h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:APVOAptevo Therapeutics Inc
30/03/202314h03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APVOAptevo Therapeutics Inc
07/03/202322h44Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:APVOAptevo Therapeutics Inc
07/03/202322h31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APVOAptevo Therapeutics Inc
14/02/202316h16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APVOAptevo Therapeutics Inc
12/12/202216h33TipRanksAptevo Skyrockets on Promising Clinical DataNASDAQ:APVOAptevo Therapeutics Inc
10/11/202214h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APVOAptevo Therapeutics Inc
30/03/202214h31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:APVOAptevo Therapeutics Inc
29/03/202213h56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APVOAptevo Therapeutics Inc
22/11/202123h29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APVOAptevo Therapeutics Inc
02/11/202114h00GlobeNewswire Inc.BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of DirectorsNASDAQ:APVOAptevo Therapeutics Inc
20/08/202112h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APVOAptevo Therapeutics Inc
11/05/202114h56Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)NASDAQ:APVOAptevo Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:APVO

Dernières Valeurs Consultées

COIN
XRPUSD
Ripple
COIN
SOLUSD
Solana
EU
EN
Bouygues
NYSE
MCD
McDonalds
COIN
BTCUSD
Bitcoin
EU
ACA
Credit Agricole
COIN
ETHUSD
Ethereum
EU
VIV
Vivendi
EU
RI
Pernod Ricard
NASDAQ
AMZN
Amazon.com
COIN
DOGEUSD
Dogecoin
EU
RNO
Renault
NYSE
NKE
Nike
EU
GLE
Societe Generale
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés